Tien Lee, Aardvark Therapeutics CEO
January 24, 2025 03:36 AM ESTUpdated 06:20 AM
Financing
Startups

Obe­si­ty biotech Aard­vark files for IPO to ad­vance oral, hunger-sup­press­ing drug

Kyle LaHucik

Senior Reporter

Aard­vark Ther­a­peu­tics filed for an IPO Thurs­day night, mak­ing it the sixth biotech in line this year for a po­ten­tial list­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

The cru­cial obe­si­ty da­ta to watch for this year

No­vo Nordisk’s amy­cretin prompts 22% weight loss in ear­ly obe­si­ty tri­al

Mod­er­na in­for­ma­tion chief to re­tire next month; Pharm­ing looks to Flag­ship for first new CEO since 2008

Boehringer merges can­cer vac­cine and on­colyt­ic virus teams; Dan­tari sells off as­sets

As­traZeneca al­lo­cates $570M for Cana­di­an ex­pan­sion, looks to add 700 new jobs

sponsored

Fu­el­ing More Break­throughs: Man­u­fac­tur­ing In­no­va­tion to Ex­pand Gene Ther­a­py’s Reach

A service from the Financial Times